Report cover image

Gastric Bands and Balloons Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Publisher GlobalData
Published Jun 20, 2022
Length 81 Pages
SKU # GBDT17342745

Description

Gastric Bands and Balloons Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Summary

GlobalData's Medical Devices sector report, “Gastric Bands and Balloons Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Gastric Bands & Balloons pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Medical devices that are used to perform bariatric surgery are referred to as bariatric surgery devices.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Gastric Bands & Balloons under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Gastric Bands & Balloons and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to-
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Gastric Bands & Balloons under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

81 Pages
2 Table of Contents
1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Gastric Bands & Balloons Overview
4 Products under Development
4.1 Gastric Bands & Balloons - Pipeline Products by Stage of Development
4.2 Gastric Bands & Balloons - Pipeline Products by Segment
4.3 Gastric Bands & Balloons - Pipeline Products by Territory
4.4 Gastric Bands & Balloons - Pipeline Products by Regulatory Path
4.5 Gastric Bands & Balloons - Pipeline Products by Estimated Approval Date
4.6 Gastric Bands & Balloons - Ongoing Clinical Trials
5 Gastric Bands & Balloons - Pipeline Products under Development by Companies
5.1 Gastric Bands & Balloons Companies - Pipeline Products by Stage of Development
5.2 Gastric Bands & Balloons – Companies Pipeline Products by Stage of Development
6 Gastric Bands & Balloons Companies and Product Overview
6.1 3DT Holdings LLC Company Overview
6.1.1 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview
6.2 Allurion Technologies, Inc. Company Overview
6.2.1 Allurion Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.3 Apollo Endosurgery Inc Company Overview
6.3.1 Apollo Endosurgery Inc Pipeline Products & Ongoing Clinical Trials Overview
6.4 Applied Medical Resources Corporation Company Overview
6.4.1 Applied Medical Resources Corporation Pipeline Products & Ongoing Clinical Trials Overview
6.5 Asensus Surgical Inc Company Overview
6.5.1 Asensus Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.6 Columbia University Company Overview
6.6.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview
6.7 CR Bard Inc Company Overview
6.7.1 CR Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
6.8 EndoRetics Inc. Company Overview
6.8.1 EndoRetics Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.9 EndoVx Inc Company Overview
6.9.1 EndoVx Inc Pipeline Products & Ongoing Clinical Trials Overview
6.10 Gelesis Inc Company Overview
6.10.1 Gelesis Inc Pipeline Products & Ongoing Clinical Trials Overview
6.11 GI Dynamics Inc Company Overview
6.11.1 GI Dynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.12 Hangzhou Tangji Medical Technology Co Ltd Company Overview
6.12.1 Hangzhou Tangji Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.13 Hebrew University of Jerusalem Company Overview
6.13.1 Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview
6.14 Innovia LLC Company Overview
6.14.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
6.15 Johns Hopkins University Company Overview
6.15.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
6.16 Mayo Clinic Company Overview
6.16.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
6.17 Medi-Globe GmbH Company Overview
6.17.1 Medi-Globe GmbH Pipeline Products & Ongoing Clinical Trials Overview
6.18 MetaModix, Inc Company Overview
6.18.1 MetaModix, Inc Pipeline Products & Ongoing Clinical Trials Overview
6.19 Nanyang Technological University Company Overview
6.19.1 Nanyang Technological University Pipeline Products & Ongoing Clinical Trials Overview
6.20 Nitinotes Surgical Ltd Company Overview
6.20.1 Nitinotes Surgical Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.21 PandaMed Company Overview
6.21.1 PandaMed Pipeline Products & Ongoing Clinical Trials Overview
6.22 Precision Medical Devices Inc Company Overview
6.22.1 Precision Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
6.23 ReShape Lifesciences Inc Company Overview
6.23.1 ReShape Lifesciences Inc Pipeline Products & Ongoing Clinical Trials Overview
6.24 Satiety Inc (Inactive) Company Overview
6.24.1 Satiety Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.25 Sensate LLC Company Overview
6.25.1 Sensate LLC Pipeline Products & Ongoing Clinical Trials Overview
6.26 Silhouette Medical Inc Company Overview
6.26.1 Silhouette Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.27 SLIMEDICS LTD Company Overview
6.27.1 SLIMEDICS LTD Pipeline Products & Ongoing Clinical Trials Overview
6.28 The Sheikh Zayed Institute for Pediatric Surgical Innovation Company Overview
6.28.1 The Sheikh Zayed Institute for Pediatric Surgical Innovation Pipeline Products & Ongoing Clinical Trials Overview
6.29 Tulip Medical Ltd. Company Overview
6.29.1 Tulip Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
6.30 University of Florida Company Overview
6.30.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview
6.31 University of Miami Company Overview
6.31.1 University of Miami Pipeline Products & Ongoing Clinical Trials Overview
6.32 ValenTx Inc Company Overview
6.32.1 ValenTx Inc Pipeline Products & Ongoing Clinical Trials Overview
6.33 Vibrynt, Inc. (Inactive) Company Overview
6.33.1 Vibrynt, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
7 Gastric Bands & Balloons- Recent Developments
7.1 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results
7.2 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase
7.3 May 23, 2022: ReShape Lifesciences Reports First Quarter 2022 Financial Results and Provides Corporate Update
7.4 May 18, 2022: Gelesis to Participate in Upcoming Investor Conferences
7.5 May 16, 2022: ReShape Lifesciences to Announce Financial Results for the First Quarter Ended March 31, 2022 and Provide Corporate Update
7.6 May 09, 2022: Gelesis to Report First Quarter 2022 Financial Results on May 12, 2022
7.7 May 04, 2022: Munson Healthcare Names Primary Care Service Line Medical Director
7.8 Apr 28, 2022: Boston Scientific reports net sales of $3.03bn in Q1 2022
7.9 Mar 31, 2022: Vizient Medical Device tech watch provides trends in transcatheter valve replacement and a model for assessing new technology in musculoskeletal care
7.10 Mar 31, 2022: ReShape Lifesciences™ to Announce Financial Results for the First Quarter Ended March 31, 2022 and Provide Corporate Update
7.11 Mar 28, 2022: ReShape Lifesciences Reports Year Ended 2021 Financial and Operating Results and Provides Corporate Update
7.12 Feb 10, 2022: TriSalus Life Sciences expands clinical executive team and scientific advisors in support of company’s focus to overcome liver and pancreatic cancer treatment barriers and enable more patients to benefit from immunotherapy
7.13 Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
7.14 Nov 11, 2021: ReShape Lifesciences Reports Third Quarter and Nine Month 2021 Financial and Operational Results
7.15 Nov 08, 2021: ReShape Lifesciences to Report Third Quarter 2021 Financial and Operational Results on Thursday, November 11, 2021
7.16 Nov 08, 2021: Boston Scientific Announces Upcoming Conference Schedule
7.17 Oct 27, 2021: Boston Scientific Announces Results For Third Quarter 2021
7.18 Oct 15, 2021: PENTAX announces expansion of Vizient contract to include pediatric endoscopic products and solutions
7.19 Sep 13, 2021: ReShape Lifesciences to Host Exhibit at Bariatric Summit
7.20 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Gastric Bands & Balloons - Pipeline Products by Stage of Development
Table 2: Gastric Bands & Balloons - Pipeline Products by Segment
Table 3: Gastric Bands & Balloons - Pipeline Products by Territory
Table 4: Gastric Bands & Balloons - Pipeline Products by Regulatory Path
Table 5: Gastric Bands & Balloons - Pipeline Products by Estimated Approval Date
Table 6: Gastric Bands & Balloons - Ongoing Clinical Trials
Table 7: Gastric Bands & Balloons Companies - Pipeline Products by Stage of Development
Table 8: Gastric Bands & Balloons – Companies Pipeline Products by Stage of Development
Table 9: 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Gastric Sleeve Magnetic Implant - Product Status
Table 11: Gastric Sleeve Magnetic Implant - Product Description
Table 12: Allurion Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Elipse Balloon - Product Status
Table 14: Elipse Balloon - Product Description
Table 15: Allurion Technologies, Inc. - Ongoing Clinical Trials Overview
Table 16: Elipse Balloon - The BALLOON- (Balloon Treatment for Obesity in Norway) Pilot Study
Table 17: Apollo Endosurgery Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: ORBERA Intragastric Balloon System - NASH - Product Status
Table 19: ORBERA Intragastric Balloon System - NASH - Product Description
Table 20: Applied Medical Resources Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Next Generation Bariatric Surgical Device - Product Status
Table 22: Next Generation Bariatric Surgical Device - Product Description
Table 23: Asensus Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Intraluminal Gastroplasty Device - Obesity - Product Status
Table 25: Intraluminal Gastroplasty Device - Obesity - Product Description
Table 26: Columbia University Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Gastric Bypass Shunt - Product Status
Table 28: Gastric Bypass Shunt - Product Description
Table 29: CR Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Restore Suturing System - Product Status
Table 31: Restore Suturing System - Product Description
Table 32: EndoRetics Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Endoretics Device - Product Status
Table 34: Endoretics Device - Product Description
Table 35: EndoVx Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 36: EndoVx Device - Product Status
Table 37: EndoVx Device - Product Description
Table 38: Gelesis Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Gelesis100 - Adolescent - Product Status
Table 40: Gelesis100 - Adolescent - Product Description
Table 41: PLENITY - Product Status
Table 42: PLENITY - Product Description
Table 43: GI Dynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 44: EndoBarrier Flow Restrictor - Product Status
Table 45: EndoBarrier Flow Restrictor - Product Description
Table 46: EndoBarrier Liner With EndoBarrier Restrictor - Product Status
Table 47: EndoBarrier Liner With EndoBarrier Restrictor - Product Description
Table 48: GI Dynamics Inc - Ongoing Clinical Trials Overview
Table 49: EndoBarrier Liner With EndoBarrier Restrictor - Endoscopic Treatment of Obesity with a Duodenal-jejunal Bypass Sleeve: Does Impairment of Fat Absorption Explain Weight Loss
Table 50: Hangzhou Tangji Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 51: Gastric Bypass Stent System - Product Status
Table 52: Gastric Bypass Stent System - Product Description
Table 53: Hangzhou Tangji Medical Technology Co Ltd - Ongoing Clinical Trials Overview
Table 54: Gastric Bypass Stent System - A Prospective, Open-label, Multicenter, Single-arm Clinical Study to Evaluate the Safety and Performance of the Gastric Bypass Stent System as a Weight Loss Treatment for Obesity
Table 55: Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview
Table 56: MetaboShield - Product Status
Table 57: MetaboShield - Product Description
Table 58: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Gastric Balloon - Product Status
Table 60: Gastric Balloon - Product Description
Table 61: Laparoscopic Band - Product Status
Table 62: Laparoscopic Band - Product Description
Table 63: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
Table 64: Image-guided Bariatric Arterial Embolization Device - Product Status
Table 65: Image-guided Bariatric Arterial Embolization Device - Product Description
Table 66: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
Table 67: Endoscopic Therapy Device - Obesity - Product Status
Table 68: Endoscopic Therapy Device - Obesity - Product Description
Table 69: Medi-Globe GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 70: Medi-Globe Gastric Balloon - Product Status
Table 71: Medi-Globe Gastric Balloon - Product Description
Table 72: MetaModix, Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 73: Endosleeve - Product Status
Table 74: Endosleeve - Product Description
Table 75: Second Generation Liner Device - Product Status
Table 76: Second Generation Liner Device - Product Description
Table 77: Nanyang Technological University Pipeline Products & Ongoing Clinical Trials Overview
Table 78: Gastric Clip - Product Status
Table 79: Gastric Clip - Product Description
Table 80: Nitinotes Surgical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 81: EndoZip System - Product Status
Table 82: EndoZip System - Product Description
Table 83: Nitinotes Surgical Ltd - Ongoing Clinical Trials Overview
Table 84: EndoZip System - Evaluation of EndoZip System in Obese Patients who Failed to Reduce Weight with Non-surgical Weight-loss Methods
Table 85: PandaMed Pipeline Products & Ongoing Clinical Trials Overview
Table 86: Intragastric Balloon System - Product Status
Table 87: Intragastric Balloon System - Product Description
Table 88: Precision Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 89: Flow Control Device - Obesity - Product Status
Table 90: Flow Control Device - Obesity - Product Description
Table 91: ReShape Lifesciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 92: ReShape Vest - Product Status
Table 93: ReShape Vest - Product Description
Table 94: ReShape Lifesciences Inc - Ongoing Clinical Trials Overview
Table 95: ReShape Vest - An Investigative, Prospective, Non-randomized, Multi-center Study to Assess the Safety and Effectiveness of a Novel Gastric Restrictive Device, Call the ReShape Vest, in People Who Are Obese
Table 96: Satiety Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 97: TOGA System - Product Status
Table 98: TOGA System - Product Description
Table 99: Sensate LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 100: Sensate Anchored Gastric Device - Product Status
Table 101: Sensate Anchored Gastric Device - Product Description
Table 102: Silhouette Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 103: nObese Device - Product Status
Table 104: nObese Device - Product Description
Table 105: SLIMEDICS LTD Pipeline Products & Ongoing Clinical Trials Overview
Table 106: Intra Gastric Implant - Product Status
Table 107: Intra Gastric Implant - Product Description
Table 108: The Sheikh Zayed Institute for Pediatric Surgical Innovation Pipeline Products & Ongoing Clinical Trials Overview
Table 109: Obesity Balloon - Product Status
Table 110: Obesity Balloon - Product Description
Table 111: Tulip Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 112: Tulip Capsule - Product Status
Table 113: Tulip Capsule - Product Description
Table 114: University of Florida Pipeline Products & Ongoing Clinical Trials Overview
Table 115: Mutated Gene Repair System - Obesity - Product Status
Table 116: Mutated Gene Repair System - Obesity - Product Description
Table 117: University of Miami Pipeline Products & Ongoing Clinical Trials Overview
Table 118: EEA Anvil Placement Device - Product Status
Table 119: EEA Anvil Placement Device - Product Description
Table 120: ValenTx Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 121: ValenTx Endoluminal Bypass System - Product Status
Table 122: ValenTx Endoluminal Bypass System - Product Description
Table 123: ValenTx Inc - Ongoing Clinical Trials Overview
Table 124: ValenTx Endoluminal Bypass System - An Open Label Trial of the Safety and Effectiveness of the ValenTx Endo Bypass System and Use of the Endoscopic Anchor Placement Device in Obese Subjects
Table 125: ValenTx Endoluminal Bypass System - Safety and Efficacy of the ValenTx EndoPass System for the Treatment of Obese Subjects: The ePass Clinical Trial
Table 126: Vibrynt, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 127: PREVAIL Implant System - Product Status
Table 128: PREVAIL Implant System - Product Description
Table 129: Glossary
2.2 List of Figures
Figure 1: Gastric Bands & Balloons - Pipeline Products by Stage of Development
Figure 2: Gastric Bands & Balloons - Pipeline Products by Segment
Figure 3: Gastric Bands & Balloons - Pipeline Products by Territory
Figure 4: Gastric Bands & Balloons - Pipeline Products by Regulatory Path
Figure 5: Gastric Bands & Balloons - Pipeline Products by Estimated Approval Date
Figure 6: Gastric Bands & Balloons - Ongoing Clinical Trials

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us